Oxycodone Pill Identifier: Mallinckrodt M30 Blue Tablets, E712 Percocet, OP 80 Green ER, and Counterfeit Fentanyl Alerts
Oxycodone Pill Identifier: Mallinckrodt M30 Blue Tablets, E712 Percocet, OP 80 Green ER, and Counterfeit Fentanyl Alerts
A forensic pharmaceutical guide to verifying authentic M30 blue, E712 yellow, and OP 80 green oxycodone tablets while identifying lethal street counterfeits.
CLINICAL TABLET IDENTIFIER
EXECUTIVE CLINICAL SUMMARY
Visual and physical verification of oral oxycodone tablets is the most critical forensic safeguard against fatal prescription poisoning in North America. Because single-entity oxycodone IR 30mg tablets—most notably Mallinckrodt’s small, round, pale blue “M30” tablet—command exorbitant prices on illegal black markets, illicit transnational cartels manufacture millions of fake “M30” pills pressed with lethal synthetic fentanyl and nitazenes. Genuine FDA-approved tablets are manufactured with exact microscopic tolerances, specific color formulations, precise debossings, and tamper-resistant coatings across strengths.
01. Comprehensive forensic identification matrix: Major formulations
The forensic matrix below compiles physical verification standards for FDA-approved brand and generic oxycodone oral formulations.
| MEDICATION / BRAND | STRENGTH | COLOR / SHAPE | OBVERSE (FRONT) | REVERSE (BACK) | NDC NUMBER |
|---|---|---|---|---|---|
| Oxycodone IR (Mallinckrodt) | 30mg Pure Opioid | Light Blue / Round | M in Square Box | 30 / Clean Bisect Score Line | 0406-0030 |
| Oxycodone IR (KVK-Tech) | 30mg Pure Opioid | Light Blue / Round | K 9 | Blank | 10702-0009 |
| Oxycodone IR (Actavis) | 30mg Pure Opioid | Light Blue / Round | A 215 | Bisect Score Line | 0591-2436 |
| Percocet (Endo / Vintage) | 10mg / 325mg APAP | Yellow / Oval Oblong | E 712 | 10 / 325 / Scored | 0603-4997 |
| OxyContin ER (Purdue) | 80mg Extended-Release | Green / Round Coated | OP | 80 | 59011-0480 |
| OxyContin ER (Purdue) | 40mg Extended-Release | Yellow / Round Coated | OP | 40 | 59011-0440 |
| OxyContin ER (Purdue) | 20mg Extended-Release | Pink / Round Coated | OP | 20 | 59011-0420 |
02. Forensic specifications: Authentic Mallinckrodt M30 blue tablets
Authentic Mallinckrodt M30 tablets have specific visual and tactile signatures:
- Color: Pale, very light powdery blue (not dark teal or royal blue). The color is uniform throughout the core with zero blue speckling or mottling.
- The “M” Imprint: The letter “M” is debossed inside a crisp square box. Crucially, the “M” has distinctive arched shoulders that do not touch the outer box edges.
- The “30” Imprint: The reverse face features the number “30” cleanly stamped above a functional bisect score line. The numbers have flat-bottomed vertical sidewalls.
- Tablet Edge: Beveled edge with smooth, hard enamel finish that does not flake or leave powdery blue dust on skin.
03. The “Dirty Thirty” fentanyl epidemic: How to spot lethal street counterfeits
The DEA’s National Forensic Laboratory reports that counterfeit “M30” pills represent the single greatest source of overdose deaths in the United States. Clandestine cartels press industrial chalk and binding glue mixed with illicit fentanyl into fake “M30” dies. Over 70% of analyzed counterfeit M30s contain lethal doses of fentanyl (ranging from 2mg to 9mg per pill). Critical counterfeit red flags include:
- Color Inconsistency: Bright turquoise, dark cyan, or chalky white with dark blue speckles.
- Crumbly Texture: Easily crushed between thumb and forefinger; leaves heavy powdery residue in plastic baggies.
- Misaligned Stampings: Shallow, crooked “M” box, irregular or distorted “30” debossings, or asymmetrical score lines.
- Uneven Thickness: When stacking multiple pills, visible variation in tablet height is apparent.
04. Percocet E712 yellow oblong identification
Endo’s generic Percocet 10/325mg (distributed under Vintage/Qualitest) is an elongated yellow oblong tablet. Key forensic markers include “E 712” cleanly debossed on the front, with “10/325” separated by a bisect score on the reverse. The yellow dye (FD&C Yellow No. 6 Aluminum Lake) is uniformly dispersed with zero streaking.
05. Tamper-resistant OxyContin OP 80 green tablets
Modern Purdue OxyContin tablets feature the “OP” imprint (replacing older abuse-prone “OC” formulations). OP 80 tablets have an indestructible polyethylene oxide polymer matrix: when struck with a hammer, the tablet flattens like hard plastic rather than shattering into powder. When placed in water, it forms an un-syringeable thick gelatinous sludge, preventing intravenous injection and snorting.
06. Detailed Receptor Neurobiology, CYP2D6 Hydromorphone Bioactivation & APAP Synergy
At the molecular and clinical level, Oxycodone combines two distinct, synergistic analgesic compounds designed to attack nociceptive signaling through dual central and peripheral mechanisms:
1. Hydrocodone Component: Hydrocodone is a semi-synthetic phenanthrene opioid agonist that binds selectively to the μ-opioid receptor (MOR) on primary afferent neurons in the dorsal horn substantia gelatinosa and brainstem periaqueductal gray (PAG). Receptor coupling to inhibitory Gi/o proteins inhibits adenylyl cyclase, closes N-type voltage-gated calcium channels, and stimulates inward-rectifying potassium channels. This hyperpolarizes neuronal membranes, dramatically inhibiting presynaptic release of substance P, glutamate, and neurokinins.
Furthermore, hydrocodone undergoes critical hepatic O-demethylation catalyzed by cytochrome P450 2D6 (CYP2D6) into hydromorphone. Hydromorphone exhibits a 6- to 10-fold higher binding affinity for μ-opioid receptors than parent hydrocodone, contributing significantly to clinical analgesia. Patients who are CYP2D6 poor metabolizers experience diminished pain relief, whereas ultra-rapid metabolizers risk exaggerated sedation and respiratory depression.
2. Acetaminophen (APAP) Component: Acetaminophen produces analgesia primarily through central inhibition of cyclooxygenase (COX-1, COX-2, and putative central COX-3/peroxidase variants) and modulation of endogenous cannabinoid and descending serotonergic inhibitory pathways. Unlike NSAIDs, APAP lacks peripheral anti-inflammatory effects and does not cause gastric ulceration or platelet inhibition.
| PHARMACOLOGICAL AGENT | PRIMARY MOLECULAR TARGET | HEPATIC METABOLIC ENZYME | CLINICAL ANALGESIC ROLE | CRITICAL CLINICAL HAZARD |
|---|---|---|---|---|
| Hydrocodone | μ-Opioid Receptor (MOR) Agonism | CYP2D6 (to Hydromorphone) & CYP3A4 (to Norhydrocodone) | Blocks ascending nociceptive pain signaling in spinal cord | Respiratory depression, physical dependence, constipation |
| Acetaminophen (APAP) | Central COX / Peroxidase Site Inhibition | Glucuronidation (55%), Sulfation (30%), CYP2E1 (to NAPQI) | Synergistic pain threshold elevation; opioid-sparing effect | Hepatotoxicity / Centrilobular necrosis at >4,000mg/day |
| Hydromorphone (Metabolite) | High-Affinity μ-Opioid Agonist (Ki ~0.37 nM) | Phase II Glucuronidation via UGT2B7 | Potent amplification of central analgesic efficacy | Toxicity in CYP2D6 ultra-rapid metabolizers |
| NAPQI (Reactive Metabolite) | Hepatocyte macromolecules | Detoxified by intracellular glutathione (GSH) | None (Toxic intermediate) | Glutathione depletion leads to irreversible liver failure |
The combination of hydrocodone with acetaminophen creates potent therapeutic synergy, enabling lower doses of the opioid component while maximizing relief for moderate to severe acute musculoskeletal and post-surgical pain.
07. Hepatic Clearance, Renal Impairment & Beers Criteria Safety
Pharmacokinetic clearance of Oxycodone involves dual metabolic pathways for both hydrocodone and acetaminophen, requiring strict clinician oversight across specific organ impairment subgroups:
| PATIENT POPULATION | PHARMACOKINETIC KINETICS | DOSING MODIFICATION DIRECTIVE | CRITICAL CLINICAL MANDATE |
|---|---|---|---|
| Hepatic Impairment (Mild-Moderate) | Impaired APAP glucuronidation and reduced hydrocodone clearance | Cap APAP ≤2,000mg / 24 hours; extend dosing intervals to Q8H-Q12H | Monitor transaminases; avoid in acute hepatitis or liver decompensation |
| Severe Hepatic Cirrhosis (Child-Pugh C) | Glutathione depletion; severe hydrocodone metabolic shunting | CONTRAINDICATED: Extreme hepatotoxicity & encephalopathy risk | NAPQI accumulation precipitates fatal hepatic centrilobular necrosis |
| CYP2D6 Poor Metabolizers (~7% Caucasians) | Minimal conversion of hydrocodone to active hydromorphone | Evaluate alternative analgesics; do not dangerously escalate dose | Escalating doses causes toxic hydrocodone/APAP buildup without pain relief |
| CYP2D6 Ultra-Rapid Metabolizers | Rapid, massive bioactivation into hydromorphone | Initiate at 50% standard starting dose; monitor breathing | High risk of sudden, life-threatening respiratory depression |
| Renal Impairment (CrCl < 30 mL/min) | Prolonged hydrocodone elimination half-life; APAP metabolite retention | Increase dosing intervals to every 8 to 12 hours | Monitor for severe cognitive blunting and respiratory depression |
| Geriatric Patients (≥ 65 Years) | Decreased hepatic mass, diminished renal clearance, CNS sensitivity | Start at lowest manufactured dose (e.g. 5/325mg); Beers Criteria oversight | Proactive bowel management mandatory to prevent severe fecal impaction |
Absolute Daily Acetaminophen (APAP) Ceiling: Under FDA regulations, the total cumulative daily dose of acetaminophen from all sources combined (including OTC cough/cold elixirs, sinus remedies, and headache pills) must never exceed 4,000mg per 24 hours. For chronic or elderly patients, clinicians recommend a safer conservative threshold of 3,000mg daily (or ≤2,000mg in chronic alcohol consumers) to protect hepatic glutathione reserves.
08. Comprehensive Patient Clinical Safety & Dispensing Checklist
Before initiating therapy or taking each scheduled dose of Oxycodone, patients, caregivers, and clinical teams must review this standardized clinical verification checklist to prevent life-threatening adverse drug events and fatal toxicities:
PATIENT PRE-ADMINISTRATION SAFETY CRITERIA
- Total Acetaminophen (APAP) Audit: Verify that the patient is not taking ANY other products containing acetaminophen (e.g., Tylenol, DayQuil, NyQuil, Excedrin, Percocet). Total APAP from all sources must never exceed 4,000mg/day (clinically target ≤3,000mg/day).
- Absolute Alcohol Prohibition: Strict zero-tolerance for alcohol. Ethanol massively accelerates liver glutathione depletion (triggering acute liver failure from APAP) while paralyzing brainstem respiratory drive alongside hydrocodone.
- Concurrent Benzodiazepine & Sedative Screen: Check for co-prescribed anti-anxiety drugs (alprazolam, diazepam, lorazepam) or sleep aids. The FDA Boxed Warning strictly advises against co-prescribing without active emergency naloxone on site.
- Emergency Naloxone (Narcan) Access: Ensure household members or caregivers know the location of emergency naloxone nasal spray and how to administer it in case of accidental overdose or respiratory collapse.
- Proactive Bowel Regimen Initiation: Opioids inevitably cause opioid-induced constipation (OIC) by paralyzing gastrointestinal motility. Daily fluid intake, dietary fiber, and scheduled osmotic or stimulant laxatives (senna, PEG 3350) should begin with the very first dose.
- Locked Storage & Disposal Safeguards: Store securely in a locked lockbox out of sight and reach of children, visitors, and pets. Accidental single-tablet ingestion of 10mg hydrocodone can cause fatal respiratory arrest in a toddler.
09. Verified Pharmaceutical Formulations & Prescribing Profiles
Oxy M30 (Oxycodone IR 30mg)
Immediate-release 30mg oral tablets for severe acute post-surgical and breakthrough cancer pain.
Percocet E712 (Oxycodone / APAP 10/325mg)
Dual-action combination analgesic for moderate to severe acute musculoskeletal trauma and surgical recovery.
Oxy 80mg Green (Oxycodone ER)
Continuous 12-hour extended-release formulation indicated exclusively for opioid-tolerant chronic cancer pain.
10. Frequently Asked Questions
What pill is small, round, light blue, and stamped with M 30?
An authentic light blue round pill with an “M” inside a box on one side and “30” with a score line on the other is generic Oxycodone Hydrochloride Immediate-Release 30mg manufactured by Mallinckrodt Pharmaceuticals.
Why are blue M30 pills so dangerous on the street?
Illicit cartels produce millions of fake “M30” pills that look identical to real medicine but actually contain deadly amounts of illicit synthetic fentanyl. The DEA reports that 7 out of 10 fake prescription pills contain a lethal dose of fentanyl.
What is the yellow oval pill stamped with E 712?
A yellow oblong pill stamped with “E 712” on the front and “10/325” on the back is generic Percocet (Oxycodone 10mg / Acetaminophen 325mg).
Can you crush an OP 80 green pill?
No. Authentic OP 80 pills are manufactured with a specialized tamper-resistant plastic-like polymer. If you try to crush them, they flatten into gummy discs and turn into thick gel in liquid to prevent abuse.
11. Clinical References & Regulatory Sources
- FDA CDER. Pillbox Database: Tablet Imprint and Visual Identification for Oxycodone HCl. Source Database.
- United States Drug Enforcement Administration (DEA). Counterfeit Pills Fact Sheet: Fake M30 Fentanyl Overdose Crisis. Source Database.
- United States Pharmacopeia (USP). Dissolution, Friability, and Uniformity Standards for Compressed Opioid Tablets. Source Database.
Consult a Clinical Pharmacy Specialist
Have questions regarding Oxycodone dosing intervals, CYP enzyme interactions, or physician-guided discontinuation protocols? Connect with our licensed clinical pharmacy team for patient safety guidance.
Related Patient Services & Verified Care
Every prescription order is verified by a licensed pharmacist in strict adherence to FDA BeSafeRx protocols.